Authorization

DGAP-News: Medios AG introduces new analytical method for identifying counterfeit drugs

DGAP-News: Medios AG / Key word(s): Miscellaneous


Medios AG introduces new analytical method for identifying counterfeit drugs


19.03.2019 / 11:00



The issuer is solely responsible for the content of this announcement.


Corporate News

Medios AG introduces new analytical method for identifying counterfeit drugs



Foundation of subsidiary Medios Analytics GmbH as part of the market roll-out




Optimisation of organisation through combination of all the Medios Group's activities


Berlin, 19 March 2019 - Medios AG ('Medios'), one of the leading Specialty Pharma companies in Germany, has rolled out its innovative analytical method for identifying counterfeit drugs following a successful trial period. Processing of the first customer orders will commence shortly. In addition, Medios has founded the subsidiary Medios Analytics GmbH in which all of the activities of the Drug Safety business unit are to be consolidated.

The new analytical method enables users to identify the content of a drug package by thermal radiation, meaning the packaging does not have to be opened. Therefore, the active ingredient remains sterile and can continue to be used to produce infusion solutions. The thermal radiation measurement results are checked against the data files of a reference library developed by Medios to see whether the drug is an original or counterfeit. The entire process takes just approximately one minute. As such, Medios's new analytical method is quicker, safer and cheaper than traditional methods which require the opening of the packaging.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Декабрь 2022    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
262728293031